NanoLogix, Inc. (NNLX)

OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Dec 31, 2025
-99.00%
Market Cap 163.00
Revenue (ttm) 1.27K
Net Income (ttm) -1.95M
Shares Out 162.89M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,000
Average Volume 312,693
Open 0.0000
Previous Close 0.0001
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0401
Beta -32.00
RSI 44.33
Earnings Date n/a

About NanoLogix

NanoLogix, Inc., a biotechnology company, provides diagnostics of viable microorganisms and viruses. It offers rapid viral assay test, which is a method for detection and quantification of a virus; and N-assay diagnostics that furnish the ability to detect and identify bacteria and other microorganisms for pharmaceutical, industrial, veterinary, and environmental testing, as well as microbiology, soil microbiology and bioremediation, microbial physiology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity sectors. The company sells its... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Bret Barnhizer
Employees 7
Stock Exchange OTCMKTS
Ticker Symbol NNLX
Full Company Profile

Financial Performance

In 2011, NanoLogix's revenue was $892, an increase of 39.38% compared to the previous year's $640. Losses were -$1.86 million, -29.93% less than in 2010.

Financial Statements

News

There is no news available yet.